Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Small conductance calcium-activated potassium channel protein 3 (KCa2.3) is a voltage-independent potassium channel that is activated by submicromolar concentrations of intracellular calcium [1, 2]. It functions as a heterotetramer, often associated with calmodulin, which acts as the calcium sensor to trigger channel opening [1]. KCa2.3 is predominantly expressed in the nervous system, vascular endothelium, and the heart, where it regulates membrane potential and cellular excitability [3]. In neurons, it contributes to the afterhyperpolarization phase following an action potential, thereby controlling firing patterns [1, 5].\n\nIn the vasculature, KCa2.3 is a major driver of endothelium-dependent hyperpolarization, which promotes vasodilation and regulates blood pressure [2, 3]. Pathologically, KCa2.3 dysfunction is linked to atrial fibrillation, hypertension, and neuropsychiatric conditions, while its overexpression in certain tumors facilitates cell migration and metastasis [3, 4]. Therapeutic targeting of KCa2.3 involves small molecule modulators like SKA-31 (activator) or apamin (blocker) to manage cardiovascular and neurological disorders [2, 3].
KCa2.3 channels open in response to increased intracellular calcium levels, allowing potassium ions to flow out of the cell, which results in membrane hyperpolarization and a subsequent reduction in cellular excitability and calcium signaling.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small conductance calcium-activated potassium channel protein 3 (KCa2.3) (KCa2.3).